Overview
Muhammad Raza is a Hematologist Oncology specialist and a Hematologist in Memphis, Tennessee. Dr. Raza is highly rated in 27 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 49 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
80 Humphreys Center Dr Ste 330, Memphis, TN 38120
6027 Walnut Grove Rd Ste 206, Memphis,, TN 38120
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Laboratory Corporation Of America Holdings
Raymond Osarogiagbon is a Hematologist Oncology specialist and a Hematologist in Southaven,, Mississippi. Dr. Osarogiagbon is highly rated in 11 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Lung Adenocarcinoma, and Endoscopy.
St. Jude Children's Research Hospital
Marcin Wlodarski is a Hematologist and an Oncologist in Memphis, Tennessee. Dr. Wlodarski is highly rated in 15 conditions, according to our data. His top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Dyskeratosis Congenita, Bone Marrow Transplant, and Splenectomy.
St. Jude Children's Research Hospital
Amar Gajjar is a Hematologist and an Oncologist in Memphis, Tennessee. Dr. Gajjar is highly rated in 13 conditions, according to our data. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, Diffuse Midline Glioma H3 K27M-Mutant, and Posterior Fossa Decompression.
Frequently Asked Questions about Dr. Muhammad Raza
How do I make an appointment with Dr. Muhammad Raza?
You can book an appointment with Dr. Muhammad Raza by calling their office at 901-752-6131. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Muhammad Raza a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Muhammad Raza is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Muhammad Raza specialize in?
While Dr. Muhammad Raza is a Hematology Oncology, they have specific expertise in Multiple Myeloma, Acute Myeloid Leukemia (AML), and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Muhammad Raza participate in research or clinical trials?
Yes. Dr. Muhammad Raza has published 49 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Muhammad Raza's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Muhammad Raza accept my insurance?
Dr. Muhammad Raza accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 901-752-6131 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Raza isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Multiple MyelomaDr. Raza isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Monoblastic Leukemia (AmoL)
- Acute Myeloblastic Leukemia with Maturation
- AgranulocytosisDr. Raza isAdvanced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Raza isAdvanced. Learn about Aplastic Anemia.
- Bone Marrow AspirationDr. Raza isAdvanced. Learn about Bone Marrow Aspiration.
- Experienced
- Acute Eosinophilic PneumoniaDr. Raza isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Raza isExperienced. Learn about Acute Mountain Sickness.
- Acute Myelomonocytic LeukemiaDr. Raza isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Raza isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Raza isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung Cancer